Tag: Non stimulant

Adderall is a potent stimulant, while Strattera is a non-stimulant medication, representing the core distinction between the two prominent ADHD treatments. The primary difference between Adderall and Strattera lies in their mechanism of action and classification, which dictates everything from onset and duration to potential for abuse and side effect profile.

Atomoxetine, an FDA-approved non-stimulant for ADHD, carries a boxed warning about the risk of suicidal thoughts in children and adolescents. A comprehensive understanding of **what are the side effects of the drug atomoxetine** is essential for both patients and caregivers, covering a range of potential reactions from common occurrences to serious, rare events.

According to 2022 data from the CDC, over 7 million U.S. children aged 3–17 have been diagnosed with ADHD. Atomoxetine is a non-stimulant medication primarily used to answer the question: **what is atomoxetine used for?** It's a key treatment for Attention-Deficit/Hyperactivity Disorder (ADHD).

Available in two formulations, guanfacine is a centrally acting alpha-2A adrenergic receptor agonist used to treat both attention deficit hyperactivity disorder (ADHD) and high blood pressure. The specific condition it is prescribed for depends on whether the patient is taking the immediate-release (IR) or extended-release (ER) version.

Over 6 million children in the U.S. have been diagnosed with ADHD, a condition impacting attention and behavior. In the realm of non-stimulant treatments for ADHD, a prominent answer to what is an example of a NaRI drug is atomoxetine, also known by the brand name Strattera.

In 2023, over 3 million prescriptions for atomoxetine (Strattera) were filled in the United States [1.5.4]. For many adults starting this non-stimulant ADHD medication, a primary concern is: **Does Strattera cause constipation?** Yes, it is a common side effect, particularly in adults [1.2.1, 1.10.5].

An estimated 3.4% of adults worldwide have ADHD, and for many, medication is a key part of treatment. While stimulants are often a first-line option, atomoxetine offers a unique approach for those who cannot tolerate or prefer an alternative treatment pathway. This article explores in detail what atomoxetine does for ADHD and how it impacts the brain.

According to a 2022 survey, over 7 million children in the U.S. have been diagnosed with ADHD [1.11.1]. For many, medication is a key part of treatment, but it's vital to understand all potential side effects. The question of *Can Strattera cause confusion?* is an important one for patients and caregivers to explore.

According to a 2024 study, up to 51% of adults with ADHD also suffer from co-morbid anxiety, making finding the right medication crucial. For those whose anxiety is worsened by stimulant medication, understanding what is the alternative to Adderall that doesn't cause anxiety is the first step toward effective treatment.

Yes, atomoxetine is FDA-approved for the long-term (maintenance) treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children, adolescents, and adults. This non-stimulant medication demonstrates maintained efficacy and a manageable safety profile during extended use, offering a valuable option for chronic ADHD management.